Circulating Tumor Cell Counts (Ctc) As Prognostic Of Overall Survival (Os) In Swog S0421-Docetaxel With Or Without Atrasentan For Metastatic Castration Resistant Prostate Cancer (Mcrpc)

Nicholas J. Vogelzang,Benjamin Ely,Louis M. Fink,Amir Goldkorn,Catherine M. Tangen,Przemyslaw Twardowski,Peter J. Van Veldhuizen,Neeraj Agarwal,Michael Anthony Carducci,J. P. Monk,Ram H. Datar,Mark Garzotto,Philip C. Mack,Primo Lara,Celestia S. Higano,Maha Hussain,David I. Quinn,Richard J. Cote,Ian Murchie Thompson

JOURNAL OF CLINICAL ONCOLOGY（2012）

引用 23|浏览39

暂无评分

摘要

10503 Background: CTC are promising biomarkers in mCRPC but have not been prospectively validated for docetaxel treatment (Rx). Using CellSearch technology (Ju0026J), we enumerated CTC in this Phase 3 ...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要